3rd Quarter - Report

SANOFI US SERVICES INC. for SANOFI US SERVICES INC

Firm
Client
Income
—
Expenses
$760,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues related to Border adjustability tax; issues related to H.R.4993; issues related to H.R.4993 "Vaccine Access Improvement Act of 2018"; and issues related to Orphan Drug Tax Credit

Foreign entity interest: Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
MARYANNE DOLBEARE DUNLAP —
JUAN MACHADO —
KATIE OPPENHEIM —
AMY L REDL —
ELIZABETH STOWER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4993 (115th)

Copyright/Patent/Trademark CPT

Issues with march-in rights within H.R 2810 National Defense Authorization Act for Fiscal Year 2018; issues related to Compulsory Licensing.

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
MARYANNE DOLBEARE DUNLAP —
ELIZABETH STOWER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2810 (115th)

Health Issues HCR

Issues related to S.2315 "Over-the-Counter Drug Safety, Innovation, and Reform Act; general issues related to drug pricing;issues related to cosmetic regulations; issues related to insulin pricing;issues related H.R. 6378 "Pandemic and All Hazards Preparedness (PAHPA)Advancing Innovation Act"; issues related to Medicare Part D; issues related to flu and Veterans Affairs; issues related to seasonal influenza vaccination; issues related to 340B Reform; issues related to Drug Importation; issues related to vaccine safety;issues related to HR5333 "Over-the-Counter Monograph Safety, Innovation, and reform Act of 2018; issues related to HR2212 "CREATES Act of 2017";issues related to HR 2439 "Fair Accountability and Innovation Research Drug Act of 2017"; issues related to Medicare rebate disclosure; issues related to S. 2852 "Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018"; issues related to S. 297 "Increasing Competition in Pharmaceuticals Act"; and issues related to S.2465 "Sickle Cell Disease and other Heritable Blood Disorders Research, Surveillance, Prevention and Treatment Act of 2018"

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
MARYANNE DOLBEARE DUNLAP —
JUAN MACHADO —
KATIE OPPENHEIM —
AMY L REDL —
ELIZABETH STOWER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2212 (115th), H.R. 6378 (115th), S. 2315 (115th), H.R. 5333 (115th), S. 2852 (115th), S. 297 (115th), S. 2465 (115th), H.R. 2439 (115th)

Budget/Appropriations BUD

Issues related to Biomedical Advanced Research and Development Authority (BARDA)" funding;and Part D and other issues related to HR1892 "Bipartisan Budget Act of 2018.

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
MARYANNE DOLBEARE DUNLAP —
JUAN MACHADO —
KATIE OPPENHEIM —
AMY L REDL —
ELIZABETH STOWER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1892 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.